Levy Health has raised $4.5 million in seed funding to further develop its clinical decision support platform for fertility diagnosis. The round was led by XYZ Ventures, with participation from Atlantic Labs and Possible Ventures. Founded in 2022 by Caroline Mitterdorfer, Silvia Hecher, and Dr. Theresa Vilsmaier, Levy Health aims to speed up the process of diagnosing fertility issues in women. The…
Beli, a company known for its fertility and prenatal supplements, has launched at-home fertility testing kits for both men and women. This new offering aims to provide users with data-driven insights into their reproductive health, complementing Beli’s existing line of supplements. The company has partnered with IHDLab to develop these testing kits. For men, the test measures four key fertility hormones: Testosterone,…
In a significant move that’s turning heads in the fertility benefits industry, e-commerce giant Amazon has reportedly chosen Maven Clinic to replace Progyny as its primary fertility benefits provider. This development, highlighted in a recent J.P. Morgan analyst report, marks a notable moment in the competitive landscape of digital health and family care services. Anu Duggal, an investor in Maven through Female…
U-Ploid, a venture-backed biotech company, has introduced its new platform designed to enhance the quality of older egg cells, a critical factor in increasing the success rates of in vitro fertilization (IVF) for women experiencing age-related infertility. The company’s technology aims to repair decades of accumulated damage in eggs, thereby improving their viability during IVF treatments. Age-related fertility decline affects millions worldwide,…
Organon China has announced a licensing and supply agreement with Shanghai Bao Pharmaceutical (BaoPharma) and its wholly-owned subsidiary, Suzhou Centergene Pharmaceuticals. Through this partnership, Organon acquires the exclusive commercialization rights to Centergene’s investigational asset, SJ02, in Mainland China. SJ02, developed by Centergene, is a long-acting recombinant human follicle-stimulating hormone carboxyl-terminal peptide fusion protein (FSH-CTP). It is designed for controlled ovarian stimulation (COS)…
Canadian life sciences company PacBio has announced the launch of the HiFi Solves Sub-fertility Consortium, a collaboration between five leading medical centers across the Asia-Pacific region. The consortium, spearheaded by KK Women’s and Children’s Hospital (KKH) in Singapore, aims to utilize PacBio HiFi long-read sequencing technology to enhance the diagnosis and treatment of subfertility and recurrent pregnancy loss (RPL). The initiative is…
Carrot Fertility, a leading company in fertility and family-building care, has launched CarrotMatch for maternity, a new pregnancy navigation system designed to connect members with the best pregnancy providers for their specific needs. The tool leverages a unique dataset that evaluates providers across more than 200 metrics, ensuring that members are matched with the highest quality and most cost-effective care available. CarrotMatch…
Tennis legend Maria Sharapova has joined Cofertility as their newest investor, bringing her influence and financial backing to the startup. Cofertility aims to make egg freezing more accessible and affordable by linking it with egg donation, offering women the opportunity to freeze their eggs for free when they donate half to intended parents who are unable to conceive. Sharapova, who retired from…
